[{"title": "Karyopharm Therapeutics Inc (KPTI) Q2 2025 Earnings Call Highlights: Navigating Financial ... - Yahoo Finance", "description": "<a href=\"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPZTBQWDlYeER5OUJmQXhDc3AxR3gwUFpqc1c3ZTdhWWZZS1JaeVgwbk5MRGlVa01LYTZvTjhYa2k1SnE5MUNyUkYtUFpDbndDLXB3X3hXSEcydThsSE5WN01ZVU5TSFpiQUlmbXZlS3NBd1dKbzZ6alVFeGNkMXdXa0tRSUh5TjhK?oc=5\" target=\"_blank\">Karyopharm Therapeutics Inc (KPTI) Q2 2025 Earnings Call Highlights: Navigating Financial ...</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>", "publishedAt": "Tue, 12 Aug 2025 07:03:26 GMT"}, {"title": "Karyopharm Therapeutics Inc. SEC 10-Q Report - TradingView", "description": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNeDJwRTNLZ0VsazVvOC1KLVJCSExwVmp1czd6U0xJaVVsSWhnQnF3OGZsZmt1RjlTSFQ4MTlfbUJINDNobXJIX0duWjZYV2h5RkhMRzZwWFFUSmtXWmcycXNKSnVOb2dWdHl6VFhFbnVFR1BsY3hVQTZOTzRpYlVqSGc1UHBwUWZTMXVvMXZSSzlSc0kyZndESmRJSC1yMDNIdFd3X01RMW8?oc=5\" target=\"_blank\">Karyopharm Therapeutics Inc. SEC 10-Q Report</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TradingView</font>", "publishedAt": "Mon, 11 Aug 2025 11:43:00 GMT"}, {"title": "US$25.92: That's What Analysts Think Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Is Worth After Its Latest Results - simplywall.st", "description": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">US$25.92: That's What Analysts Think Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Is Worth After Its Latest Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>", "publishedAt": "Thu, 14 Aug 2025 12:01:57 GMT"}, {"title": "Karyopharm Therapeutics Inc. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:KPTI) - Seeking Alpha", "description": "<a href=\"https://news.google.com/rss/articles/CBMisAFBVV95cUxNM2x6aDVfTzlXR1dadkZDX0RRNW82YWo5VzYtMTVxNk40OWFfTVJmU3pOZi1nOHF1d2FKR1BsY0ZOUWVuSTNpdXhRVnVLT3c4TUcxam1CaVh1dTlnU2tmVTZ1NGNRWDFsVUNmOE9ONTZHSk4xMGJiWlQzRHpKcHRFM0FnRkVEamJpU3BObTE4NVF3NmNfLXIzbERwemszTWdNRWpuam8xeUE1Ym9Tek45WQ?oc=5\" target=\"_blank\">Karyopharm Therapeutics Inc. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:KPTI)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>", "publishedAt": "Mon, 11 Aug 2025 15:03:53 GMT"}, {"title": "Multi Factor Analysis Ranks Karyopharm Therapeutics Inc. as Strong Buy - Momentum Based Equity Trading Plans Reviewed - beatles.ru", "description": "<a href=\"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNQXp6Tkp0NkFuWDBnQ1VOVDY3YklVby13OHI5N0VaMVduSFRSQ0M1VWhGczAyTGtjOXJMWEQ1d1pFTnVFUWFFSmZvaF9mZ2QwbTE0azM4Yktycnc3aksxTkRhZExKTE1sVW1DX01WOXAtWUkwX2xKa2FXVkp6U04zUi1GTnk5OUFKNDZocVctaFZfb2hKTmtNa3d3TjNxamptUURvaVh6dnNfdw?oc=5\" target=\"_blank\">Multi Factor Analysis Ranks Karyopharm Therapeutics Inc. as Strong Buy - Momentum Based Equity Trading Plans Reviewed</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">beatles.ru</font>", "publishedAt": "Mon, 11 Aug 2025 06:51:28 GMT"}, {"title": "Karyopharm Therapeutics: Q2 Earnings Snapshot - New Haven Register", "description": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxPT0t6bHpHN01FcmFORHBvb05mMVFRWFo3UTM0TTJHSG1ubVhHWHNla3hyQmowclIyMVpvc3kwYjhDR0p4ZXh4WWQtUVJZT3lLbjhQSGtyTHdZbUFVLUZaam50N1hlc2dRSjNwRHpxSFNiek83TG42dExtNGFWT3FKQ0NXcjJFTHJyaEpxSFlXQXpmckg3Sk9BdkJRa2NIZG9JNDRN?oc=5\" target=\"_blank\">Karyopharm Therapeutics: Q2 Earnings Snapshot</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">New Haven Register</font>", "publishedAt": "Mon, 11 Aug 2025 21:56:15 GMT"}, {"title": "Karyopharm Therapeutics Reports Q2 2025 Earnings - TipRanks", "description": "<a href=\"https://news.google.com/rss/articles/CBMiogFBVV95cUxQWTNqVU5lSG43ZzFnQ3ZvMnJtWGRLb3J4RDZ1SEhRbXcweWNpV2xEeFRDMFNIMmJOeWVWT1RFa0pDTGdMYlhxcVVxWHlOX3kzNDBManZ5VFNmcjNEZjFwRUNDNXFlUkRDQTNEWEJMaWlRR1NhTWx2QTRnRkNQeDVqZ0EwcG9hZ1otWlo2MDYwX2xFcDBoaFRjWVdVXzRjWXRNZFE?oc=5\" target=\"_blank\">Karyopharm Therapeutics Reports Q2 2025 Earnings</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>", "publishedAt": "Tue, 12 Aug 2025 04:10:55 GMT"}, {"title": "Karyopharm Therapeutics\u2019 SWOT analysis: biotech firm\u2019s stock faces pivotal year - Investing.com", "description": "<a href=\"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPN0prMjlaMzlrV0I0cmtwd3BzYmhYTURiSGNKQlBqc0FaMFJnckJvbXdveUFuQ1ZGUzRxdUFmc2p6V1BxWmV5NHZIcFBzZVJGeDNXTjBuOEdVOUV4aHpmOUhDYldwWlNaZVRhb09DX2xNc3Y5STFjQ18wN2ZxTXpUU0ZGTHF1VmRxNGFkVUJqbWZHM3d4THpMVkZkZW04Y1I0VnlqbnlnQ2cwbl9vRTQtbTVLbDRhOXYwbU5YdmVjY3ZaajluejJBZA?oc=5\" target=\"_blank\">Karyopharm Therapeutics\u2019 SWOT analysis: biotech firm\u2019s stock faces pivotal year</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com</font>", "publishedAt": "Wed, 13 Aug 2025 19:30:00 GMT"}, {"title": "Karyopharm Therapeutics shares rise 1.03% premarket after reporting Q2 earnings. - AInvest", "description": "<a href=\"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNXzkwMVFRUFZCNGtFVGtsb2VubWpWVlF4R1paaFlaZ1lQY29tc0lfaHdmbmQ4emdzWUp3ZVU0ZDNHWEJUR1lkRXVWdXJWaUlqeDExTVRfSFVjRW5TaDFwTEIwS1Y0X3dQQVVWSDI4SmxsWGFKQlJOOWp0UWQxQ1NsMC1oSHdwRFdvYjZDNzRwTnloUC1aUUNsc3I2emFSOS1nZ1R5SE9obGEtUGs?oc=5\" target=\"_blank\">Karyopharm Therapeutics shares rise 1.03% premarket after reporting Q2 earnings.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AInvest</font>", "publishedAt": "Tue, 12 Aug 2025 13:10:47 GMT"}, {"title": "Karyopharm Therapeutics (KPTI) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance", "description": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxPczAtVnhSZEhrNktfT1ZDQ3pWcndXVGhZN3BYLVc5UWFRbUhqUDZqclVmOHF5aEZ2MF9Kc3RoWktuc3VtdTJmWndOY3lPaTBYNm1wOXVrVlVYbC1ET3dVeU1EaHpEaURLajNJVXBSNFlWUlVMYy1ybDN1TXNfWnVaaG9RV3NmRktiT1lORldn?oc=5\" target=\"_blank\">Karyopharm Therapeutics (KPTI) Reports Q2 Loss, Lags Revenue Estimates</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>", "publishedAt": "Mon, 11 Aug 2025 23:00:03 GMT"}, {"title": "Karyopharm Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingView", "description": "<a href=\"https://news.google.com/rss/articles/CBMi8gFBVV95cUxQd1F1alF6dFRxUUU1ZFdPaFJDNWcyaGVFRWpfaGRIRWQ1eEtUYm9XVkpERTFfTzYtaC1EeWd4bEw4cklWb2JacDNhenFwOG1MZEtQRVRUdDQ1MXBkN2hGekJ5c2NzZjRpWGVGcUZ6UVIySzVnTGF5ZU9kdkxVTlZBQWZ2Qk1rNE4yNW9yT01pdkU1QnR2V1E4REZMWC1yNlF1OVppZW5jYkhwTmpNMGh2YjgtaU94Yl9jTW42Njh0ZnhtcE90T1dPSXNGNE9FQmZWS2JJLW42VHRRX0o3YVVXZXc3MlBLd3RGY2xveU1BaVJzQQ?oc=5\" target=\"_blank\">Karyopharm Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TradingView</font>", "publishedAt": "Mon, 11 Aug 2025 13:31:56 GMT"}, {"title": "Karyopharm Therapeutics Inc. Builds Base for Possible Rebound - Oversold Bounce Stock Play Ideas Gain Attention - beatles.ru", "description": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxObDg4ZjNmbE5kbXRMM0NMaG5DX0F3bzE4bGs1NWdyOTZ2OUZFSV9VS0NGcERmRE1TNDdKMDl4U1hHVW5LRVpleHRqSlJ1S2lRUThoMTdDUUNnVExkOFhPM1JwVGR2dkM2R1Y2TW5xT3REZm56aEFaNXVielpDemRJYy1neGRYUzVFVnVnN1ZwdzFFMXc?oc=5\" target=\"_blank\">Karyopharm Therapeutics Inc. Builds Base for Possible Rebound - Oversold Bounce Stock Play Ideas Gain Attention</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">beatles.ru</font>", "publishedAt": "Tue, 12 Aug 2025 12:04:20 GMT"}, {"title": "Karyopharm Therapeutics Inc (KPTI) Q2 2025 Earnings Call Highlights: Navigating Financial ... By GuruFocus - Investing.com Canada", "description": "<a href=\"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNOXJNZTNZREdvQUdsbjBTemtiLXFrdW9zU2gtdEZCYUxXSEx3SWVXM24yVzVlVmotQkZfSzlqblM5d3lZaHNlbnJaNDd0MkJJZFQxajItQmxCVVZRRkF2SGpzWVllQUctQU5IVDBieEZZRC1ETEZLbmRCN3dkNThpT2diN3lEM3I4VU9ZbkZxSVYtQWI0amZRLUVfTGlGYXVnRXcxUmUzMjY2ZkJoUVNyMmRzQzJ5QURJYmNZY3hmQ2FHUFVvVWVIbDlVRXdZVHFZZ3BiZQ?oc=5\" target=\"_blank\">Karyopharm Therapeutics Inc (KPTI) Q2 2025 Earnings Call Highlights: Navigating Financial ... By GuruFocus</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com Canada</font>", "publishedAt": "Tue, 12 Aug 2025 06:33:45 GMT"}, {"title": "How to read the order book for Karyopharm Therapeutics Inc. - July 2025 Drop Watch & Capital Protection Trading Alerts - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMilAFBVV95cUxQNXhXS0Y4R2xHaWVyaVVjOERqVG9BNXFabmVQQVpBamRmNGFUVzlVTU5oNUdWODdjM1ZYUjlsbGh2TGJNNkJVc3ZodnZieVo1OE9HUExVR0h0dnA2ZHpuZUpDRnlTa2VKWUdGR1NSMVNGc204a3BWTk9QZXZSVjFpR1cwUkZZRENWSFE5SFA2M2QzcjZp?oc=5\" target=\"_blank\">How to read the order book for Karyopharm Therapeutics Inc. - July 2025 Drop Watch & Capital Protection Trading Alerts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Sat, 16 Aug 2025 10:07:24 GMT"}, {"title": "Advanced analytics toolkit walkthrough for Karyopharm Therapeutics Inc. - Market Growth Report & High Conviction Investment Ideas - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQSGJhYW9PSlZnVVZKdFBBUk9BRkowSDRieHVnU2J1cnpiVUdYQXdMalNRcV85SnJfNDNQRnFvTXZkck56U29POFVwMC10aW14d0JTQUh0cnNmRnR6aFpoVnZTenNCWDhNSmhYMDVBbTVSY1NFMFByb2FJNEd0TTY2emMzaDF5LWZET0UxY0FfVVA0WG9XOGFMUUJkX29oX0xoZ0lSbVRXSlY?oc=5\" target=\"_blank\">Advanced analytics toolkit walkthrough for Karyopharm Therapeutics Inc. - Market Growth Report & High Conviction Investment Ideas</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Fri, 15 Aug 2025 19:52:14 GMT"}, {"title": "What makes Karyopharm Therapeutics Inc. stock attractive to long term investors - Quarterly Trade Report & Proven Capital Preservation Methods - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxPSmRpN3NNYTJscWlIbVF0VnRDVFF6X1EyWDB6VktiVXVxN09vY2tnUVNRSUNrT3FBMjlyMmVMTG1YemNNN1VqWURHR1hiWHlvbHR5dXUtSGo3UXhBaER1RFFFYjJpT0R0V3ZlYlNTWldaTGJFNkNCMGpGbU5RX2pVTS0tTzMwQnlhbHNDekxDUEdZVWJlZV9IT185aHF4TTNId3lIdDBFd2c4QVpzSEJPSlNR?oc=5\" target=\"_blank\">What makes Karyopharm Therapeutics Inc. stock attractive to long term investors - Quarterly Trade Report & Proven Capital Preservation Methods</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Fri, 15 Aug 2025 17:03:29 GMT"}, {"title": "Is Karyopharm Therapeutics Inc. meeting your algorithmic filter criteria - July 2025 Trade Ideas & Free Risk Controlled Daily Trade Plans - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxQVjkxdmpqRlQ0N2tRNmJhU3FUcHFETU9KQzRpd1dfVWI3aG9Dbzg5Z2VRMTl0TURZSEZueFpaR3Fqa25vcGc1SHMtSjZDU3VIaUtMYkZEWnVKQ2Vfd1llakw3bFZ6bzJmUl9hVlkwM0xLcUJjX193bk5KY2MteUFCRDFRZUNnU2NlQ1ZBd3BRVmpVUGlCM084ekVmcHpKU3NBbWIyMQ?oc=5\" target=\"_blank\">Is Karyopharm Therapeutics Inc. meeting your algorithmic filter criteria - July 2025 Trade Ideas & Free Risk Controlled Daily Trade Plans</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Sat, 16 Aug 2025 03:16:17 GMT"}, {"title": "What makes Karyopharm Therapeutics Inc. stock price move sharply - Value Investing Checklist with Entry Signals - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMimwFBVV95cUxNeWZGMjItc0hlaVlRWlRhSXljWkZvemVyNFl5Y21tRXhoRUJyQ2lNR09wWXNwajBkaHNaRDk1Q0VIaXVNZFhpSVBfQm01a19iMEJZb1dQd3BYemFkaURQQXhyNlZCSHZzd1dubnViLXRTMU1RU2FKUkVDTTQ0Q0JxSDJxRXBuYjFJWlh3WUJka1o1SXdXVGlFME1Hdw?oc=5\" target=\"_blank\">What makes Karyopharm Therapeutics Inc. stock price move sharply - Value Investing Checklist with Entry Signals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Sun, 10 Aug 2025 03:09:07 GMT"}, {"title": "Karyopharm Therapeutics Inc. stock prediction for this week - Trade Volume Report & Free Weekly Chart Analysis and Trade Guides - Newser", "description": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxPREdWU2I3Q2NGdHdGYmFsQnBCcVhxcWE3Sldwa19pY1NXTkNuVUNLSDZ4ZVR1RTEwRlBJczB1NWg3QlVuejRqcjdLaXg0VzRHakFlNklFcmdkUkpJYmt3aUF5RW9fRGlPb0NwSS0zZjZFWG1IRTIwZTdDZVdycm83a3d3bDh4ZHIxN3NUZnFkdDgyWUc4SG14Ng?oc=5\" target=\"_blank\">Karyopharm Therapeutics Inc. stock prediction for this week - Trade Volume Report & Free Weekly Chart Analysis and Trade Guides</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Newser</font>", "publishedAt": "Sat, 16 Aug 2025 11:08:04 GMT"}, {"title": "Karyopharm Therapeutics (NASDAQ:KPTI) Given New $25.00 Price Target at Robert W. Baird - Defense World", "description": "<a href=\"https://news.google.com/rss/articles/CBMixAFBVV95cUxNa1pHamdaaHJGQmUyQkZlRmtpYWdHT0dzblg2RFVfRDhlY04yaVZfcl90MHVoRmMyeWRlbFc2T2N4SDBHNnRFN19seVRNMGNfS1FOTmNaMDJFMVZBUjFlU3dSYXpaOWh0TVVKUF9Dd0I0NEVmYTRydGxzMWV4Vllyc010cWZLQWhNa29qdG1JM3h3VnpGcmtIdmcwYnlxbkdFOHE0bUVETVByQXBoakhZYkVhY282ZGw4UV9leXprazF0RXA2?oc=5\" target=\"_blank\">Karyopharm Therapeutics (NASDAQ:KPTI) Given New $25.00 Price Target at Robert W. Baird</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Defense World</font>", "publishedAt": "Wed, 13 Aug 2025 06:43:00 GMT"}]